ArticleFrontiers in psychiatry2022

Case report: Prazosin augmentation for treating comorbid treatment-resistant depression and chronic post-traumatic stress disorder.

Ping Guo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.